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Abstract. An outbreak of encephalitis with a case fatality rate of 78.3% was investigated among children in Gujarat
State, India. Twenty-six cases were reported. Three patients had IgM antibodies to Chandipura virus. Virus was isolated
from one patient with rhabdomyosarcoma in porcine stable cell lines and in suckling mice. Chandipura virus RNA was
present in 9 of 20 acute-phase serum samples, and virus sequences from the present outbreak were closely related to
prototype strain (1965) and Andhra Pradesh, India (2003) isolates. Serologic and molecular assays documented the
absence of Japanese encephalitis virus, West Nile virus, dengue virus, and paramyxoviruses in clinical samples. The
etiologic agent was Chandipura virus, which has become an important encephalitis-causing virus in India.
INTRODUCTION
Viral encephalitis is an important public health problem
worldwide. Chandipura (CHP) virus, a rhabdovirus, is trans-
mitted to humans by sand flies. Vesiculoviruses were isolated
in 1965 in the Chandipura (Nagpur) region of India in two
adult patients with febrile illness1 during an outbreak of fe-
brile illness caused by chikungunya and dengue viruses. Sub-
sequently, CHP virus was isolated from a child with acute
encephalitis in Raipur in central India.2 This virus was not
considered to have an epidemic potential until an outbreak of
acute encephalitis in children in Andhra Pradesh, India was
attributed to CHP virus in 2003.3 During this outbreak, a
case-fatality rate of more than 55% was recorded. A similar
outbreak of encephalitis in children was observed in Gujarat
State in western India in 2004.
In India, most epidemics of encephalitis in children have
previously been associated with Japanese encephalitis (JE).4
However, several outbreaks of encephalitis with high mortal-
ity remained undiagnosed, with the first reported as early as
1954 in Jamshedpur in central India,5 followed by those in
Nagpur in 1958, in Raipur in 1965,6 and more recently in the
Warangal District of Andhra Pradesh in 1997 and 2002.7
These outbreaks were attributed to dengue, chikungunya vi-
rus, measles, JE, and Reye’s syndrome8 because they were
clinically indistinguishable and no definitive laboratory diag-
nosis was made. The recent outbreak in 2004 was differen-
tially diagnosed using serologic, molecular, and isolation
methods. The results of the investigations are reported here.
MATERIALS AND METHODS
Study area. The study area in India is located between 22°
and 23°N and 73° and 75°E. The cases were reported from the
Vadodara and Panchmahal districts. They are situated in the
eastern hilly region of Gujarat, bordering Madhya Pradesh
(Figure 1). This undulating region lies at an altitude of ap-
proximately 200 meters above mean sea level. The population
is mostly tribal, composed predominantly of the Bhil and
Bhilala tribes. The economy is agrarian with dry cultivation of
paddy, maize, and cotton. Rainfall in this district is due to the
southwest monsoon between June and September. Average
annual rainfall ranges between 441 mm and 1,569 mm. Pre-
monsoon showers (80 mm) were recorded in 2004; subse-
quently, there was no precipitation for the next four weeks.
Patients and clinical specimens. Case definition. A prob-
able case was defined as a patient with a sudden onset of
high-grade fever, followed by central nervous system involve-
ment, altered senses, convulsions, or a comatose state, singly
or in combination, and negative test results for malaria and
other common causes of illness. A confirmed case was de-
fined as a patient with one or more of the following labora-
tory results: presence of viral RNA, IgM antibodies against
CHP virus in a clinical sample, seroconversion in a convales-
cent sample, and virus isolation.
Clinical specimens along with a detailed clinical history
were collected from 20 patients for etiologic diagnosis. The
samples included 20 blood or serum samples, 14 throat swabs,
8 cerebrospinal fluid (CSF) samples, and 10 urine samples. In
addition, 119 blood samples were collected from apparently
healthy persons in the community. Of these, 75 were from
children (19 having a history of fever in the preceding month
and 56 without such a history). Thirty-nine of these children
resided in villages that had an encephalitis case and 36 resided
in unaffected neighboring villages. All 44 adults tested (26
recovered fever cases and 18 without a history of fever) lived
in the affected villages. A second blood sample was collected
from one recovered case 12 days post-onset of disease.
Samples were collected after informed consent was obtained
from adults or legal guardians of minors. The study was re-
viewed and approved by the Institutional Ethics Committee
of the National Institute of Virology, which complies with the
Ethical Guidelines for Biomedical Research on Human Sub-
jects of the Indian Council of Medical Research, 2000. The
state health authorities conducted routine laboratory tests to
rule out bacterial infections, malaria, sickle cell anemia, and
other common causes of illness.
Serologic analysis. Serum samples of patients were
screened using in-house enzyme-linked immunosorbent as-
says (ELISAs) for the detection of IgM antibodies to JE vi-
rus,9 West Nile virus,10 and dengue virus.11 Sera of patients
and asymptomatic persons were tested for IgM antibodies
against CHP virus by an antigen-capture ELISA developed at
The National Institute of Virology (Maharashtra, India), as
previously reported.3 Briefly, IgM from patient serum was
captured on wells coated with anti-human IgM. Chandipura
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virus extracted from mouse brain by a sucrose-acetone
method was the source of antigen. Captured antigen was de-
tected with the IgG fraction of polyclonal anti-Chandipura
virus mouse serum conjugated with biotin (Sigma, St. Louis,
MO) and avidin-conjugated horseradish peroxidase, and o-
phenylenediamine and hydrogen peroxide were added for
color development. Negative controls included age-matched
serum from apparently healthy children from an area not
affected by the outbreak, and serum and CSF from children
with flavivirus encephalitis. The cutoff value was determined
as mean optical density for negative controls plus 3 SD.
Similarly, all sera were tested with the in vitro neutraliza-
tion test in Vero cell cultures to detect antibodies to CHP
virus.12 Briefly, Vero cells were seeded in 96-well microtiter
plates at a concentration of 3 × 104 cells/well. Aliquots of
serum samples diluted 1:10 in Dulbecco’s modified minimum
essential medium (DMEM) with 2% fetal bovine serum
(FBS) were heat-inactivated at 60°C for 20 minutes. Three-
fold dilutions of serum samples starting at 1:10 were added to
DMEM plus 2% FBS and mixed with an equal volume of 100
50% tissue culture infectious doses (TCID50s) of CHP virus
and incubated for one hour at 37°C. The serum-virus mixture
(100 L) was then transferred to Vero cell monolayers. The
CHP virus immune mouse serum was used as a positive con-
trol and normal mouse serum was used as a negative control.
Virus controls and cell controls were included in each plate
and virus titration was also carried out. The virus neutralizing
antibody titer was expressed the reciprocal of the highest an-
tibody dilution capable of neutralizing 100 TCID50s of virus.
A titer of 1:10 was considered a positive result.
Detection of viral RNA. A nested reverse transcriptase–
polymerase chain reaction (RT-PCR) was carried out for the
detection of flavivirus (serum), paramyxovirus (urine), and
enterovirus (serum) RNA in the clinical specimens according
to previously described methods.2 The enteroviral RNA-
positive PCR products were sequenced as described in this
report and the homology of the sequences was compared with
the sequences from the GenBank database using the Basic
Local Alignment Search Tool (BLAST) program (National
Center for Biotechnology Information, Bethesda, MD)
(http://www.ncbi.nlm.nih.gov/Tools/). For the detection of
CHP virus RNA, RNA from the clinical specimens was iso-
lated using the Trizol LS reagent (Life Technologies, Inc.,
Gaithersburg, MD) according to the instructions of the manu-
facturer. Following preparation of cDNA using avian myelo-
blastosis virus reverse transcriptase (Promega, Madison, WI)
for one hour at 42°C, a two-step DNA amplification was car-
ried out with 35 cycles each of denaturation at 94°C for one
minute, annealing at 55°C for one minute, and extension at
72°C for one minute. The PCR products were subjected to
electrophoresis on 2% agarose gels. The primers used were
CHAND-G-F2, 425–445: 5-GTC TTG TGG TTA TGC TTC
TGT-3; CHAND-G-R5, 750–771: 5-TTC CGT TCC GAC
CGC AAT AACT-3; CHAND-G-F5, 541–560: 5-GAG
AAT GCG ACC AGT CTT AT-3; and CHAND-G-R6,
724–744: 5-TGC AAG TTC GAG ACC TTC CAT-3. The
expected size of the nested PCR product was 204 basepairs.
Negative controls were included in all PCR assays. Pre-
amplification and post-amplification were conducted on the
different floors of the laboratory.
Sequencing and phylogenetic analysis. The PCR products
were purified using Wizard PCR preps DNA purification kit
(Promega) according to the manufacturer’s instructions and
subsequently sequenced using the Big Dye Terminator cycle
sequencing Ready Reaction Kit (Applied Biosystems, Foster
City, CA) and an automatic Sequencer (ABI PRISM 310
Genetic Analyzer; Applied Biosystems). Multiple alignments
of nucleotide sequences were carried out using Clustalx ver-
sion 1.8 (European Molecular Biology Laboratory, Heidel-
berg, Germany). Phylogenetic analysis based on the partial
glycoprotein gene (G gene) sequences (203 nucleotides) was
carried out using MEGA version 2.1 software.13 For analysis
in MEGA, the Jukes-Cantor distance model was used with
the neighbor-joining algorithm. The reliability of different
FIGURE 1. Map of Gujarat, India showing areas with cases of encephalitis. •  cases; gray lines  district borders; black lines  state borders;
MP  Madhya Pradesh.
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phylogenetic groupings was evaluated by using the bootstrap
test with 1,000 bootstrap replications available in MEGA.
The percentage nucleotide identity (PNI) was calculated by
using p-distance available in MEGA.
Isolation of the etiologic agent. Six CHP virus RNA-
positive clinical samples were inoculated intracerebrally in
two-day-old Swiss albino mice. The mice were observed for
14 days for signs of illness. For in vitro amplification of the
etiologic agent, specimens from 13 patients (7 serum, 5 whole
blood, 6 throat swabs, and 2 cerebrospinal fluid samples) were
inoculated in rhabdomyosarcoma (RD) and porcine stable
(PS) cell lines. Cultures were observed for the development
of cytopathic effects (CPEs). Cultures not showing CPEs for
three passages were considered negative for CHP virus.
Collection of sand flies. Adult sand flies were collected
from houses and peridomestic habitats in the villages with
encephalitis cases. They were transported in plastic jars and
cloth cages, identified, pooled, and stored at −70°C until pro-
cessed. Seventeen pools composed of 81 sand flies were sub-
jected to RT-PCR for detection of CHP viral RNA.
RESULTS
Clinicoepidemiologic features. Twenty-six probable en-
cephalitis cases (22 from the Vadodra district and 4 from the
Panchmahal district) were reported in children between June
9 and July 14, 2004.The case distribution was rural and spread
over three talukas (counties) in Vadodara and one taluka in
Panchmahal (Figure 1). Clustering of cases was not observed.
The male to female ratio was 1:1 and the ages of the patients
ranged between 2 and 16 years (mean age  6.03 years).
Eighteen of 23 patients died, giving a case-fatality rate of
78.3% (the outcome in three patients was not known), and 13
(72.2%) of 18 died within 24 hours of onset of disease. The
remaining deaths occurred 2–4 days post-onset of illness.
Neurologic sequelae were not observed in survivors.
Detailed clinical findings for 19 patients were available for
analysis. The most common manifestations were fever and
altered senses in all patients, convulsions in 17, vomiting in 13,
diarrhea in 10, chills preceding fever in 3, and cough in 3.
The nutritional status of the patients ranged from poor to
average. Vesicular eruptions with serous transudate and hy-
perpigmentation on healing were observed in four patients.
Tachycardia was observed, which was consistent with an in-
creased temperature. Eight of 19 patients had bilateral crepi-
tations on auscultation of the lungs. Two children had pal-
pable livers with marginally increased levels of alanine ami-
notransferase and aspartate aminotransferase. Nine children
had decreased muscle tone and power. Hemiparesis and sev-
enth cranial nerve palsy were detected in one patient. Deep
tendon reflexes were not elicitable in 13 patients, and were
normal and lower in three patients each. The plantar reflex
was elicited in 10 patients, abnormal (extensor plantar re-
sponse) in 7 patients, and equivocal in 2 patients. Cracked pot
sound was present in two patients.
Clinical laboratory test results. Hemoglobin levels ranged
from 7 to 10.5 mg% (normal range  10.5–15.5 mg%). Total
white blood cell counts ranged from 3,600 to 12,500 cells/mm3
(normal range  4500–11,000 cells/mm3). The differential
white blood cell count was neutrophils  54–80% (normal
range  54–62%), lymphocytes  20–46% (normal range 
25–35%), eosinophils < 3% (normal < 5%), and monocytes
1–2% (normal range  2–8%). The erythrocyte sedimenta-
tion rate was less than 20 mm/hour (normal <1 5 mm/hour) in
seven cases studied. Blood glucose levels ranged from 56 to
216 mg/dL (normal range  60–110 mg/dL).
The CSF in 13 patients was clear and colorless, with a nor-
mal or insignificantly increased opening pressure, and a white
blood cell count within normal limits (0–5 cells/mm3). No red
blood cells were present. The protein level was < 60 mg% in
nine patients and ranged from 90 to 210 mg% in the remain-
ing four patients (normal range  15–60 mg%). The CSF
glucose levels ranged from 10 to 120 mg/dL (normal  50%
of blood glucose levels), and were less than 50% of serum
glucose levels in two patients. C-reactive protein was absent
in all samples. No evidence of sickle celled anemia was found
in any of the children examined.
Etiologic investigations. Of the 20 clinical specimens from
13 patients analyzed, one serum sample collected two days
post-onset of symptoms (NIV-045983) showed CHP virus in
RD and PS cell lines, as well as in infant mice. This isolate was
confirmed by PCR and sequencing.
Nine (45%) of 20 acute-phase serum samples were positive
for CHP virus RNA, including that of the patient who showed
seroconversion to IgM antibodies to CHP virus in the second
sample. Flavivirus and paramyxovirus RNA was not detected
in nine serum and five urine samples, respectively. All throat
swabs, urine samples, and CSF samples were negative for
CHP viral RNA. Two serum samples were positive for en-
terovirus RNA. BLAST analysis of the two sequences
showed 96% homology with echovirus 11 and human polio-
virus 1 isolates, respectively.
All acute-phase sera were negative for IgM antibodies to
JE, dengue, and West Nile viruses. Three patients were posi-
tive for IgM antibodies to CHP virus; 2 of 20 acute-phase
samples were positive for IgM and neutralizing antibodies to
CHP virus. In addition, the only patient whose convalescent
sample was available on the day 12 post-onset of symptoms
was positive for IgM and neutralizing antibodies to CHP vi-
rus, although the acute-phase sample was negative for both
antibodies. One serum sample from a 16-year-old female was
negative for IgM antibodies to CHP virus and positive for
neutralizing antibodies to CHP virus. The neutralizing anti-
body titer was 1:90 in all patients. The remaining acute-phase
sera were negative.
Serologic tests conducted in apparently healthy population
showed that 10.6% of the children were positive for IgM
antibodies to CHP virus and 65.3% were positive for neutral-
izing antibodies (geometric mean titer [GMT]  28.17),
which was significantly lower than among patients (P < 0.01)].
Age-wise analysis showed that children less than five years of
age had a significantly low frequency of neutralizing antibod-
ies (8 of 18, 44%) compared with those more than five years
of age (28 of 38, 73.3%) (P < 0.05). Among adults, 4.5% were
positive for IgM antibodies to CHP virus and 97.7% were
positive for neutralizing antibodies (GMT  27.6).
Phylogenetic analysis. The GenBank Accession numbers
for the sequences generated during this study are AY–
871791–99. The phylogenetic status of the CHP viral se-
quences obtained from the clinical samples and one isolate
during the present outbreak is presented in Figure 2. Overall,
the PNI between different CHP viral isolates ranged from
91.1% to 100%. Of the three major clusters identified, six
Varodara sequences formed one cluster; three Andhra
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Pradesh and three Varodara sequences formed a second clus-
ter, and two Andhra Pradesh sequences and the prototype
1965 strain isolated from Maharashtra State formed the third
cluster. The PNI between groups was 96.7% (range  95–
98.5% for clusters 1 and 2), 93.8% (91.1–96.6% for clusters 1
and 3), and 95.9% (range  94.4–97.8% for clusters 1 and 2).
Thus, all sequences were closely related to each other and an
epidemic was not characterized by circulation of only one
type of isolate.
Sand fly species composition and RT-PCR results. A total
of 27 female and 54 male Sergentomyia sand flies collected
between July 9 and 11, 2004 from peridomestic habitats were
processed in 17 pools. The RT-PCR conducted on all pools
did not show any positive results.
DISCUSSION
Demonstration of CHP viral RNA in 9 (45%) of 20 cases,
IgM antibodies to CHP virus in 3 (15%) of 20 cases, and 1
isolation of CHP virus is strong evidence for CHP virus as the
etiologic agent of the encephalitis outbreak that affected chil-
dren in tribal areas in Gujarat state, India in June–July 2004.
The absence of neutralizing antibodies to CHP virus in most
(17 of 20) of the patients indicates a primary infection with
CHP virus. One patient, a 16-year-old girl, had neutralizing
antibodies to CHP virus in the absence of IgM antibodies to
this virus in an acute-phase serum sample. This is indicative of
past exposure to CHP virus and the present episode may
represent encephalitis due to an agent other than CHP virus.
Whether or not the detection of enteroviral RNA in two pa-
tients without CHP viral markers is incidental or represents
enteroviral etiology cannot be ascertained.
The results confirm the limitations of the ELISA and use-
fulness of molecular assays in the diagnosis of CHP viral en-
cephalitis with a rapid clinical course and high mortality.
Since most (13 of 18, 72.2%) of the patients died within 24
hours, IgM antibodies could be demonstrated only in 2 (10%)
of 20 patients. Importantly, one surviving patient who pro-
vided a blood sample on the 12th day post-onset of disease
was negative for IgM antibodies to CHP virus. The acute-
phase sample from this patient was negative for IgM antibod-
ies to CHP virus but positive for CHP viral RNA. Lack of
molecular/serologic evidence of CHP virus infection in 9 of 20
cases may represent the absence of viremia at the time of
sampling and/or an etiology not related to CHP virus. The
dynamics of viral RNA and antibodies in patients with CHP
viral encephalitis needs to be determined for designing ap-
propriate diagnostic methods.
Phylogenetic analysis based on conserved G gene regions
placed six Vadodara sequences in a distinct cluster and three
sequences in another cluster along with the AP isolates of
2003, suggesting co-circulation of closely related CHP viruses
in the same epidemic.
The clinical picture was consistent with that described in an
earlier outbreak.3 The mortality rate during the present epi-
sode was higher (18 of 23, 78.3%) in comparison with that in
Andhra Pradesh epidemic in 2003 (183 of 329, 55%). This
could be attributed to the poor nutritional status, lack of
proper management, the small scale of the outbreak.
Blood samples taken from healthy individuals showed that
more than 10% of children (with or without a history of fever
in the preceding month) had IgM antibodies to CHP virus,
indicating recent exposure to the virus and milder forms of
the disease, either sub-clinical or as self- resolving pyrexia. A
total of 4.5% of the adults had IgM antibodies to CHP virus
in their blood, which also indicated recent infection, although
no encephalitis cases were observed among adults. Our find-
ing of a significantly lower frequency of neutralizing antibod-
ies among younger children suggests that a significant pro-
portion of the pediatric population is susceptible to CHP virus
and is consistent with the fact that encephalitis cases occurred
only among children. Infections with CHP virus seem to be
widespread in this region, as shown by the high frequency of
neutralizing antibodies among the healthy population and the
fact that immunity increases with age, which is suggestive of
this area being endemic for CHP virus. Gujarat is the fourth
FIGURE 2. Phylogenetic analysis of Chandipura viruses based on partial G gene sequences (203 nucleotides). Percent bootstrap support is
indicated by the values at each node. The accession numbers for the Chandipura virus G gene sequences used for analysis include five sequences
from the outbreak in the state of Andhra Pradesh (AP) in 2003: AP18R (AY 614722), AP31M (AY 614721), AP27M (AY382603), AP09R (AY
614723), AP60V (AY 614720); one sequence from the state of Maharashtra in 1965: MAH6514V (AY614717); and nine sequences obtained during
this study in 2004.
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state in India to report CHP virus; the others are Maharash-
tra, Madhya Pradesh, and Andhra Pradesh.
Sand flies have been implicated as vectors of CHP virus.
However, in our study, we could did detect CHP viral RNA in
the limited samples processed. Previously, CHP virus was iso-
lated from sand flies during the outbreak in Andhra
Pradesh,14 as well as in Maharashtra.15
In conclusion, CHP virus has emerged as an important en-
cephalitis-causing pathogen in India. We emphasize the need
for immediate in-depth analysis of the transmission mecha-
nisms of this virus, including the role of vectors and other
ecologic factors, for the development of appropriate control
strategies.
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